Health News Editor
NIH Halts Patenting to Delay Treatment Development
President Donald Trump’s administration is making waves with new regulations at the National Institutes of Health, putting a damper on patenting and treatment development. These changes have not only slowed the flow of grant...
LGBTQ+ Youth Mental Health Across States: A Comprehensive Analysis
In a recent study on LGBTQ+ youth mental health conducted by the Trevor Project, new state-by-state analysis has shed light on the challenges faced by queer young people across the country. The survey, which...
Bhattacharya Nears Confirmation as NIH Director
Jay Bhattacharya, the nominee for the position of Director of the National Institutes of Health, faced a confirmation hearing on Wednesday that left many questions unanswered. Despite his reluctance to make concrete statements on...
Advisory Committee on Immunization Practices: Former Chairs Reflect
Former Chairs Reflect on the Vital Role of the Advisory Committee on Immunization PracticesAs the recent postponement of a crucial federal advisory committee meeting echoes through the healthcare landscape, concerns arise about the ability...
Suspend U.S. patents on medicines to fight U.S. tariffs
In the wake of the recent imposition of 25% tariffs on goods from Canada by the Trump administration, the Canadian government is responding with tariffs of its own. Amidst this escalating trade conflict, there...
Predicted: 1 in 6 Youth to Be Obese by 2050
In a world where health concerns are at the forefront of our minds, a recent analysis has made a startling prediction: by the year 2050, 1 in 6 young people will be classified as...
HHS Spokesman Resigns Amid Tensions with RFK Jr.
In a surprising turn of events, Thomas Corry, the top spokesman at the Department of Health and Human Services, made the decision to resign following escalating tensions with Secretary Robert F. Kennedy Jr. and...
Update on Mysterious Illness Outbreak in DRC
In the heart of the Democratic Republic of the Congo, a mysterious and deadly illness has taken hold, sending shockwaves through the local population and drawing international attention. Reports of unexplained illnesses and deaths...
Government Officials Withdraw from HIMSS Health Information Conference
Government officials set to speak at the upcoming Healthcare Information and Management Systems Society (HIMSS) meeting in Las Vegas have pulled out of the event, leaving a void in the vital health tech industry...
Reforming FDA to Help Rare Disease Patients
President Donald Trump has the potential to revolutionize the landscape of rare disease treatments and save countless American lives through strategic policy changes, innovative science, and strong leadership within government agencies. This ambitious claim...
Challenges at FDA & bluebird Bio Sale: What You Need to Know
This morning, Praxis Precision Medicine announced that an independent data monitoring committee recommended discontinuing a Phase 3 study involving its experimental treatment for essential tremors. The analysis indicated that the drug was unlikely to...
Quantifying Impact of Abrupt PEPFAR Cuts: Startling Results
Amidst the complexities of global health and foreign aid, the potential consequences of abrupt funding cuts to the President's Emergency Plan for AIDS Relief (PEPFAR) in South Africa loomed large. This critical issue, which...
